Synopsis
Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-methyl-2-pentylphenol
2. 1300-94-3
3. 5-methyl-2-n-pentylphenol
4. 6-pentyl-m-cresol
5. 6-amyl-m-cresol
6. 6-n-amyl-m-cresol
7. 6-n-pentyl-m-cresol
8. Amylmetacresolum
9. Phenol, 5-methyl-2-pentyl-
10. Amyl Metacresol
11. 2-amyl-5-methylphenol
12. Chebi:48213
13. 05w904p57f
14. Ncgc00180998-01
15. Amilmetacresol
16. Amilmetacresol [spanish]
17. Amylmetacresolum [latin]
18. Amylmetacresol [inn:ban]
19. Brn 2440952
20. M-cresol, 6-pentyl-
21. Einecs 215-094-0
22. Unii-05w904p57f
23. Amylmetacresol [inn]
24. Dsstox_cid_26791
25. Dsstox_rid_81908
26. Dsstox_gsid_46791
27. 3-06-00-02005 (beilstein Handbook Reference)
28. Amylmetacresol [vandf]
29. Schembl302197
30. Amylmetacresol [mart.]
31. Amyl Metacresol [vandf]
32. Amylmetacresol [who-dd]
33. Chembl1512677
34. Dtxsid8046791
35. 6-n-amyl-m-cresol [mi]
36. Baa30094
37. Zinc2039651
38. Amylmetacresol [ep Impurity]
39. Tox21_112651
40. Amylmetacresol [ep Monograph]
41. Mfcd00127710
42. S6173
43. Stl453583
44. Akos015912095
45. Db13908
46. 5-methyl-2-n-pentylphenol, Aldrichcpr
47. Ds-15450
48. Cas-1300-94-3
49. Hy-121527
50. Cs-0082471
51. Ft-0620948
52. Amylmetacresol 100 Microg/ml In Acetonitrile
53. A888790
54. Sr-01000944860
55. Q1946346
56. Sr-01000944860-1
57. W-108357
| Molecular Weight | 178.27 g/mol |
|---|---|
| Molecular Formula | C12H18O |
| XLogP3 | 4.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 4 |
| Exact Mass | 178.135765193 g/mol |
| Monoisotopic Mass | 178.135765193 g/mol |
| Topological Polar Surface Area | 20.2 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 133 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Sore throat, minor mouth and throat infections,,.
The mixture of amylmetacresol throat lozenge medications markedly reduces the infectivity of certain infectious viruses in the throat and in cough droplets, thus reducing opportunities for person-to-person transmission. In addition, it relieves symptoms of sore throat/irritation of the throat,. Amylmetacresol is thought to inhibit the inflammatory and pain mediators that are involved in the inflammation of the mouth and throat mucous membranes, as well as the sore throat.
Absorption
Rapidly absorbed and eliminated.
The mechanism of virucidal action is not fully elucidated, however it is suggested that denaturation of external protein spikes, a pH-induced rearrangement of the tertiary structure of attachment proteins, or a selective effect on viral lipid membranes/proteinlipid interaction is responsible for this action. Amylmetacresol is an antibacterial and antiviral agent, and blocks voltage-gated Na channels in a local anesthetic-like manner.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
27
PharmaCompass offers a list of Amylmetacresol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amylmetacresol manufacturer or Amylmetacresol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amylmetacresol manufacturer or Amylmetacresol supplier.
PharmaCompass also assists you with knowing the Amylmetacresol API Price utilized in the formulation of products. Amylmetacresol API Price is not always fixed or binding as the Amylmetacresol Price is obtained through a variety of data sources. The Amylmetacresol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 05W904P57F manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 05W904P57F, including repackagers and relabelers. The FDA regulates 05W904P57F manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 05W904P57F API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 05W904P57F manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 05W904P57F supplier is an individual or a company that provides 05W904P57F active pharmaceutical ingredient (API) or 05W904P57F finished formulations upon request. The 05W904P57F suppliers may include 05W904P57F API manufacturers, exporters, distributors and traders.
click here to find a list of 05W904P57F suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 05W904P57F CEP of the European Pharmacopoeia monograph is often referred to as a 05W904P57F Certificate of Suitability (COS). The purpose of a 05W904P57F CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 05W904P57F EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 05W904P57F to their clients by showing that a 05W904P57F CEP has been issued for it. The manufacturer submits a 05W904P57F CEP (COS) as part of the market authorization procedure, and it takes on the role of a 05W904P57F CEP holder for the record. Additionally, the data presented in the 05W904P57F CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 05W904P57F DMF.
A 05W904P57F CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 05W904P57F CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 05W904P57F suppliers with CEP (COS) on PharmaCompass.
A 05W904P57F written confirmation (05W904P57F WC) is an official document issued by a regulatory agency to a 05W904P57F manufacturer, verifying that the manufacturing facility of a 05W904P57F active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 05W904P57F APIs or 05W904P57F finished pharmaceutical products to another nation, regulatory agencies frequently require a 05W904P57F WC (written confirmation) as part of the regulatory process.
click here to find a list of 05W904P57F suppliers with Written Confirmation (WC) on PharmaCompass.
05W904P57F Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 05W904P57F GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 05W904P57F GMP manufacturer or 05W904P57F GMP API supplier for your needs.
A 05W904P57F CoA (Certificate of Analysis) is a formal document that attests to 05W904P57F's compliance with 05W904P57F specifications and serves as a tool for batch-level quality control.
05W904P57F CoA mostly includes findings from lab analyses of a specific batch. For each 05W904P57F CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
05W904P57F may be tested according to a variety of international standards, such as European Pharmacopoeia (05W904P57F EP), 05W904P57F JP (Japanese Pharmacopeia) and the US Pharmacopoeia (05W904P57F USP).
